About TCR² Therapeutics
TCR² Therapeutics Inc. is a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer.
Founded in 2015 by Patrick Baeuerle.
- Founded
- 2015
- Employees
- 125
- Total funding
- $297.3M
- Headquarters
- Cambridge
Leadership
The top of TCR² Therapeutics's org chart, with how many people report into each leader.
Alfonso Quintás Cardama
Chief Medical Officer
1 report
Chirag Khatiwala
VP, Process & Analytical Development
1 report
Eric Sullivan
CFO
Rosemary Harrison
Chief Business & Strategy Officer
Kevin Zikaras
VP, Development Operations
Viera Muzithras
VP, Regulatory Affairs
Richard Roomberg
VP, Corporate Controller
Laura Gunn
VP, Medical Affairs
Seth Clarke
CMC Project Manager
Board
Ansbert Gadicke
Director
Patrick Baeuerle
Advisor
Kai Wucherpfennig
Advisor
Wolfgang Schamel
Advisor
Stephen Webster
Director
Stephan Grupp
Advisor
Jobs at TCR² Therapeutics
No open positions right now. Explore more companies on TheJobsMap.